Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

Texas mandates the wearing of facemasks in public

July 3, 2020 Medical Communications COVID-19, coronavirus

Texas becomes the latest state in the US to mandate the wearing of facemasks in public, as COVID-19 cases skyrocket …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …
News
leicester_copyright_mat_fascione

UK Government accused of withholding Pillar 2 COVID-19 data which show Leicester had 10 times more cases than reported pre-lockdown

July 1, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, UK

The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …
News
pharmafocus_july-august_2020_cover

The July/August 2020 issue of Pharmafocus is available to read free online now!

June 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Pharmafocus, pharma

The July/August 2020 issue of Pharmafocus is available to read free online now!
News
nhs_hispioiotror

NICE to recommend Roche cancer treatment

June 26, 2020 Medical Communications NHS, NICE

NICE are set to recommend Roche’s Rozlytrek (Entrectinib) cancer treatment which will be the second histology drug to be recommended …
News

Novartis agrees to pay $347 million to settle bribery allegations

June 26, 2020 Medical Communications Greece, Novartis, bribery

Novartis and its former eye care unit Alcon have agreed to pay a combined $347 million to resolve allegations that …
News
boots

70% of BAME pharmacists in the UK have had no risk assessment for COVID-19

June 26, 2020 Medical Communications COVID-19, coronavirus

More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, …
News
remdesivir_ulrich_perrey

Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19

June 26, 2020 Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir

In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …
News
top_10_image_2_2

Top Ten most popular articles on Pharmafile.com this week

June 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …
News
pexels-photo-3044623_araruna

How is COVID-19 impacting the rare disease community?

June 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease

The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …
Feature
shutterstock

EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine

June 19, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …
News

Roche’s Tecentriq improves pathological complete response in triple-negative breast cancer at Phase 3

June 19, 2020 Medical Communications, Research and Development Cancer, Genentech, Roche, breast cancer, tecentriq

 
News
mozzie

Florida approve plan to release 750 million genetically modified mosquitoes to stop the spread of disease

June 19, 2020 Medical Communications AIDS, HIV, mosquitoes

Florida state regulators have gained approval to release 750 million genetically modified mosquitoes across the state to reduce the spread …
News
fda

FDA approves Crysvita for treating tumour-induced osteomalacia

June 19, 2020 Medical Communications FDA, FDA approvals

The FDA has approved Crysvita (burosumabtwza) injection to treat patients over two years old with tumour-induced osteomalacia (TIO). This is …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

June 19, 2020 Medical Communications COVID-19, coronavirus, top 10

The news this week centres around COVID-19 vaccines, as Moderna is to start testing 30,000 people with its vaccine beginning …
News
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026